Title: 
Official Title: To amend title XVIII of the Social Security Act to strengthen the drug
            pricing reforms in the Inflation Reduction Act.
Number of Sections: 2
Source: versions - Introduced in Senate
Media Type: text/xml

================================================================================

Section 1:
1.
            Short title
 This Act may be cited as the Strengthening Medicare And Reducing Taxpayer Prices Act or the SMART Prices Act.

Section 2:
2.
            Improvements to the Medicare Drug Price Negotiation Program
            
                (a)
                Acceleration of the selection of
                    negotiation-Eligible drugs
 Section 1192(a) of the Social Security Act (42 U.S.C. 1320f–1(a)) is amended—
                
                    (1)
 in paragraph (3)—  (A) by striking 2028, 15 negotiation-eligible drugs and inserting 2028 or a subsequent year, 50 negotiation-eligible drugs; and
                    
                    
                        (B)
 by striking ; and at the end and inserting a period; and
                    
                
                
                    (2)
 by striking paragraph (4).    (b) Improvements to the definition of qualifying single source drug Section 1192(e)(1) of the Social Security Act (42 U.S.C. 1320f–1(e)(1)) is amended—
                
                    (1)
 in subparagraph (A)(ii), by striking 7 years and inserting 3 years; and
                
                
                    (2)
 in subparagraph (B)(ii), by striking 11 years and inserting 3 years.
                
            
            
                (c)
                Improvement to the ceiling for maximum fair price
 Section 1194(c)(3) of the Social Security Act (42 U.S.C. 1320f–3(c)(3)) is amended—
                
                    (1)
 in subparagraph (A), by striking 75 percent and inserting 76 percent;
                
                
                    (2)
 in subparagraph (B), by striking 65 percent and inserting 55 percent; and
                
                
                    (3)
 in subparagraph (C), by striking 40 percent and inserting 30 percent.
                
            
            
                (d)
                Effective date
 The amendments made by this section shall apply with respect to initial price applicability years (as defined in section 1191(b) of the Social Security Act (42 U.S.C. 1320f(b))) beginning with initial price applicability year 2028.


================================================================================

Raw Text:
119 S1836 IS: Strengthening Medicare And Reducing Taxpayer Prices Act
U.S. Senate
2025-05-21
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.



        II
        119th CONGRESS
        1st Session
        S. 1836
        IN THE SENATE OF THE UNITED STATES
        
            May 21, 2025
            Ms. Klobuchar (for herself, Mr. Welch, Ms.
                    Smith, Mr. King, Ms. Cantwell, Mr.
                    Reed, Mr. Whitehouse,
                    Ms. Duckworth, Ms. Warren, Mrs. Gillibrand,
                    Mr. Merkley, Mrs. Murray, Mr. Blumenthal,
                    Mrs. Shaheen, Ms. Cortez Masto, Ms.
                Baldwin, Mr. Booker, Mr. Van Hollen, Mr.
                    Durbin, Mr. Murphy, Mr. Fetterman, Mr.
                    Markey, Mr. Luján, Ms. Hassan, Mr.
                    Heinrich, Ms. Slotkin, and
                    Mr. Bennet) introduced the following bill;
                which was read twice and referred to the Committee on Finance
        
        A BILL
        To amend title XVIII of the Social Security Act to strengthen the drug
            pricing reforms in the Inflation Reduction Act.
    
    
        
            1.
            Short title
 This Act may be cited as the Strengthening Medicare And Reducing Taxpayer Prices Act or the SMART Prices Act.
        
        
            2.
            Improvements to the Medicare Drug Price Negotiation Program
            
                (a)
                Acceleration of the selection of
                    negotiation-Eligible drugs
 Section 1192(a) of the Social Security Act (42 U.S.C. 1320f–1(a)) is amended—
                
                    (1)
 in paragraph (3)—  (A) by striking 2028, 15 negotiation-eligible drugs and inserting 2028 or a subsequent year, 50 negotiation-eligible drugs; and
                    
                    
                        (B)
 by striking ; and at the end and inserting a period; and
                    
                
                
                    (2)
 by striking paragraph (4).    (b) Improvements to the definition of qualifying single source drug Section 1192(e)(1) of the Social Security Act (42 U.S.C. 1320f–1(e)(1)) is amended—
                
                    (1)
 in subparagraph (A)(ii), by striking 7 years and inserting 3 years; and
                
                
                    (2)
 in subparagraph (B)(ii), by striking 11 years and inserting 3 years.
                
            
            
                (c)
                Improvement to the ceiling for maximum fair price
 Section 1194(c)(3) of the Social Security Act (42 U.S.C. 1320f–3(c)(3)) is amended—
                
                    (1)
 in subparagraph (A), by striking 75 percent and inserting 76 percent;
                
                
                    (2)
 in subparagraph (B), by striking 65 percent and inserting 55 percent; and
                
                
                    (3)
 in subparagraph (C), by striking 40 percent and inserting 30 percent.
                
            
            
                (d)
                Effective date
 The amendments made by this section shall apply with respect to initial price applicability years (as defined in section 1191(b) of the Social Security Act (42 U.S.C. 1320f(b))) beginning with initial price applicability year 2028.